ban on compounded semaglutide FDA GLP-1 Drugs: What to Know Drugmakers battle pharmacies over compounded

Protein intake and resistance training are critical during treatment

Aldhaleei WA, Abegaz TM, Bhagavathula AS

Key Takeaway: The main interaction risk is delayed gastric emptying, which can alter the timing and consistency of how oral blood thinners are absorbed by your body

Retatrutide's glucagon arm produces more nausea than pure GLP-1 compounds, so stabilizing it first makes it much easier to tell where any new symptom is coming from

According to the FDA prescribing information, gastrointestinal adverse reactions occur in up to 44% of patients taking Wegovy and at varying rates with Ozempic and Rybelsus depending on dose